Archives glaucoma

by in
Entry Author Date Location
East Coast Biotech Roundup: WaVe, Shkreli, Intarcia & More 08/21/15 Boston
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
East Coast Biotech Roundup: Emulate, Pulmatrix, Synergy & More 06/19/15 New York
Aerie Surges As FDA Agrees to New Goals for Glaucoma Trial 06/16/15 New York
Aerie Craters As Glaucoma Drug Comes up Short in Phase 3 04/23/15 New York
Ocular’s Long-Lasting Eye Drug Tech Passes First Late-Stage Test 03/10/15 Boston
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
Focused on Glaucoma, Aerie Looks Toward Unblinding Critical Data 03/03/15 New York
East Coast Biotech Roundup: Vertex, Syndax, Build-to-Buy Deals & More 02/20/15 Boston
Glaucoma Race Heats Up, But Inotek Cuts Back Its IPO to $40M 02/18/15 Boston
East Coast Biotech Roundup: Intercept, Idera, Inotek, & More 11/07/14 Boston
Inotek, Chasing Aerie in Glaucoma, Sets Sights on IPO 11/05/14 Boston
U-M Spinout OcuSciences Is Medical Main Street Innovator of the Year 10/16/14 Detroit Ann Arbor
West Coast Biotech Roundup: Burrill, Topol, Aduro, Receptos, & More 06/19/14 San Francisco
East Coast Biotech Roundup: ImmusanT, NY Disruptors, Tesaro, & More 03/14/14 Boston
East Coast Biotech Roundup: Vertex, Dimension, Merrimack, & More 11/01/13 Boston
Aerie Gets Lukewarm Reception, Cuts IPO Price to $10 Per Share 10/25/13 New York
East Coast Biotech Roundup: Schenkein, PureTech/JDRF, Sage, & More 10/18/13 Boston
East Coast Life Sciences Roundup: Moderna, Inotek, Roche, & More 10/04/13 Boston
Inotek Snares $21M, Stares Down Aerie in Glaucoma Drug Race 09/30/13 Boston
Aerie Pharma Eyes $58M IPO For Glaucoma Drug Push 09/18/13 New York
$3M for iScience Interventional 08/22/11 San Francisco
Antigenics Expands Experimental Cancer Treatment, Novartis Adds to Cambridge Presence, Boston Scientific Sells Unit to Stryker, & More Boston-Area Life Sciences News 10/29/10 Boston
Solx Gets $3.7M 10/28/10 Boston
Seattle Genetics’ Home Run, Acucela Growing Ties to Japan, Calistoga’s Wall Street Guy, & More Seattle-Area Life Sciences News 09/30/10 Seattle
Acucela, Strengthening Ties With Japan’s Otsuka, Gets Right to Develop New Glaucoma Drug 09/27/10 Seattle
Obama Stimulates UW, Public Biotechs Run Low on Cash, Healionics Ships Glaucoma Product & More Seattle-Area Life Sciences News 03/26/09 Seattle
Healionics Scores $2.6M Angel Backing to Promote Healing Around Medical Devices 12/11/08 Seattle
Healionics Signs Deal To Make Components for Glaucoma Device in Dogs 09/09/08 Seattle
Healionics Signs Deal To Make Components for Glaucoma Device in Dogs 08/31/08 Seattle
Page 1 of 1